<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Completeness Assessments for Type II Active Pharmaceutical Ingredient Drug Master Files Under the Generic Drug User Fee Amendments of 2012; Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Completeness Assessments for Type II Active Pharmaceutical Ingredient Drug Master Files Under the Generic Drug User Fee Amendments of 2012; Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2016-02-16 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a guidance for industry entitled "Completeness Assessments for Type II API DMFs Under GDUFA". It finalizes the draft guidance entitled "Initial Completeness Assessments for Type II API DMFs Under GDUFA", which published on October 2, 2012. This guidance is intended for holders of Type II active pharmaceutical ingredient (API) drug master files (DMFs) that are or will be referenced in an abbreviated new drug applic...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2016-02969</p>
    <p><strong>Publication Date:</strong> 2016-02-16</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2016/02/16/2016-02969/completeness-assessments-for-type-ii-active-pharmaceutical-ingredient-drug-master-files-under-the">https://www.federalregister.gov/documents/2016/02/16/2016-02969/completeness-assessments-for-type-ii-active-pharmaceutical-ingredient-drug-master-files-under-the</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2016-02969</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
